Clinical AI, drug discovery, devices, and regulatory approvals.
A sponsored analysis argues that agentic AI can reduce friction in prior authorization, claims, and member services by orchestrating existing systems, with human oversight for judgment calls.
A randomized trial found no immune benefit from holding targeted DMARDs around COVID vaccination, but a higher flare risk.
A federal appeals panel signaled it may again strike down the Medicare Advantage audit rule that Humana challenged.
New guidance from the American College of Physicians makes menopausal hormone therapy the first-line treatment for hot flashes and night sweats.
A MedPage Today explainer examines how private equity ownership can load hospitals with debt and prioritise investor returns over patient care.
A rare fungus that causes brain abscesses and can kill up to 70% of infected patients has risen sharply in U.S. lab-detected cases, CDC researchers report.
The Nobel Prize in Physiology or Medicine goes to three researchers who developed a technique for controlling brain cells with light, enabling precise mapping of neural circuits.
A sponsored healthcare analysis argues that fixing fragmented workflows matters more than adding staff to improve patient access.
A small trial found incision-free brain radiosurgery improved treatment-resistant depression and resolved suicidal ideation in 13 of 14 patients, though experts urge caution.
Annual HF STATS report projects a growing burden of heart failure and highlights the underuse of proven therapies.
A single nanoparticle treatment reduced lung tumors in mice while targeting cachexia, pointing toward a future dual-action cancer therapy.
A human gene active in brain cells still carries the machinery to move through DNA, raising new questions about its role in health and disease.
A seven-day water-only fast in 12 volunteers produced coordinated molecular changes across organs, with many effects emerging only after about three days, researchers report.
A MedCity News column argues that the industry's core problem isn't knowing what to fix, but giving clinicians and patients the tools to act in real time.
A health news roundup reports an unexplained pneumonia death in Russia, an expanded Trader Joe's recall, and gaps in opioid treatment for young Medicaid enrollees.
The cash deal adds the approved drug Aqneursa, targeting two inherited disorders, to Shionogi's growing rare disease business.
Utah will let an AI prescribe acne drugs without human review, adding third-party audits to address critics.
A STAT analysis finds that inscrutable industry prices, not just insurer behavior, are pushing premiums to levels that make employers rethink coverage.